Horizon Kinetics Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.3M	Sell	340,783 -12,578	-4%	-$551K	0.18%	42
2025 Q4	$13.7M	Sell	353,361 -1,324	-0.4%	-$50.5K	0.18%	46
2025 Q3	$12.5M	Buy	354,685 +1,214	+0.3%	+$43.9K	0.15%	49
2025 Q2	$12.7M	Buy	353,471 +23,901	+7%	+$792K	0.15%	50
2025 Q1	$10.3M	Buy	329,570 +10,394	+3%	+$329K	0.12%	54
2024 Q4	$8.14M	Buy	319,176 +90,380	+40%	+$2.4M	0.1%	57
2024 Q3	$6.47M	Buy	228,796 +12	+0%	+$332	0.1%	63
2024 Q2	$6.03M	Buy	228,784 +28,496	+14%	+$790K	0.11%	62
2024 Q1	$6.08M	Sell	200,288 -16,402	-8%	-$484K	0.12%	57
2023 Q4	$6.09M	Sell	216,690 -70,565	-25%	-$1.94M	0.13%	56
2023 Q3	$7.8M	Sell	287,255 -46,414	-14%	-$1.38M	0.15%	53
2023 Q2	$10.3M	Sell	333,669 -39,451	-11%	-$1.34M	0.22%	52
2023 Q1	$13.4M	Sell	373,120 -26,760	-7%	-$992K	0.26%	44
2022 Q4	$15.8M	Sell	399,880 -8,666	-2%	-$362K	0.26%	40
2022 Q3	$16.4M	Sell	408,546 -45,010	-10%	-$1.92M	0.33%	37
2022 Q2	$19.1M	Buy	453,556 +62,638	+16%	+$2.57M	0.4%	38
2022 Q1	$15.2M	Buy	390,918 +108,381	+38%	+$4.26M	0.31%	46
2021 Q4	$11.3M	Buy	282,537 +42,209	+18%	+$1.64M	0.25%	53
2021 Q3	$8.69M	Buy	240,328 +27,071	+13%	+$1.05M	0.2%	54
2021 Q2	$8.74M	Buy	213,257 +163,492	+329%	+$6.95M	0.18%	57
2021 Q1	$2.17M	Buy	+49,765	New	+$2.36M	0.05%	112